Amitriptyline (brand name “Elavil”) is a medication that was initially approved by the FDA in 1961 for the treatment of major depressive disorder. Due to its three-ring chemical structure, it is formally classified as a tricyclic antidepressant (TCA). Though not formally approved in the United States to treat conditions other than major depression, Amitriptyline is …
Amitriptyline (brand name “Elavil”) is a drug derived from the chemical dibenzocycloheptadiene that was discovered and approved in the early 1960s for the treatment of major depression. It is formally classified as a tricyclic antidepressant (TCA) and functions principally via inhibiting the presynaptic reuptake of norepinephrine and serotonin. This effect of dual presynaptic reuptake inhibition …
Amitriptyline (Elavil) is the most popular TCA (tricyclic antidepressant) medication on the market. It is primarily utilized for the treatment of depression, and in other cases, migraine headaches and anxiety disorders. The drug functions primarily by inhibiting the reuptake of the serotonin transporter, which increases extracellular levels of the neurotransmitter serotonin. Although serotonin is primarily …
Amitriptyline (Elavil) is a tricyclic antidepressant (TCA) that has been used to treat major depression since its approval in 1961. It is regarded as one of the most popular tricyclic antidepressants of all time and has been regarded by the World Health Organization as an “essential medicine” or a drug needed in a basic health system. …
Tricyclic Antidepressants (TCAs) were developed in the 1950s as a way to treat depression with chemical compounds. These drugs are known for their specific chemical structure consisting of three rings of atoms, hence being referred to as “tri”-cyclic. Tricyclics were developed after researchers began exploring derivatives of the first typical antipsychotic medication Thorazine. Experimentation with derivatives …